000			02127 a2200577 4500
005			20250516211741.0
264		0	_c20140729
008			201407s 0 0 eng d
022			_a1873-2968
024	7		_a10.1016/j.bcp.2014.04.014 _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Jing
245	0	0	_aAnti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells. _h[electronic resource]
260			_bBiochemical pharmacology _cJun 2014
300			_a477-89 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xantagonists & inhibitors
650	0	4	_aAutophagy _xdrug effects
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCytokines _xantagonists & inhibitors
650	0	4	_aForkhead Box Protein O1
650	0	4	_aForkhead Transcription Factors _xagonists
650	0	4	_aG2 Phase _xdrug effects
650	0	4	_aGlioblastoma _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNeoplasm Proteins _xagonists
650	0	4	_aNeoplastic Stem Cells _xdrug effects
650	0	4	_aNerve Tissue Proteins _xagonists
650	0	4	_aNeurons _xdrug effects
650	0	4	_aPhosphatidylinositol 3-Kinase _xchemistry
650	0	4	_aRNA Interference
650	0	4	_aRNA-Binding Proteins _xantagonists & inhibitors
650	0	4	_aRandom Allocation
650	0	4	_aRecombinant Proteins _xpharmacology
650	0	4	_aSecond Messenger Systems _xdrug effects
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aLiu, Libo
700	1		_aXue, Yixue
700	1		_aMeng, Fanjie
700	1		_aLi, Shuai
700	1		_aWang, Ping
700	1		_aLiu, Yunhui
773	0		_tBiochemical pharmacology _gvol. 89 _gno. 4 _gp. 477-89
856	4	0	_uhttps://doi.org/10.1016/j.bcp.2014.04.014 _zAvailable from publisher's website
999			_c23792154 _d23792154